Search Results for "prophylaxis"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for prophylaxis. Results 181 to 190 of 194 total matches.

Ranibizumab (Lucentis) for Macular Degeneration

   
The Medical Letter on Drugs and Therapeutics • Oct 23, 2006  (Issue 1246)
in Treatment Guidelines: Drugs for ADHD – November 2006 Surgical Prophylaxis – December 2006 Drugs ...
The FDA has approved ranibizumab (Lucentis - Genentech) as an intravitreal injection for treatment of neovascular (wet) age-related macular degeneration (AMD). Ranibizumab is a derivative of bevacizumab (Avastin), which is FDA-approved for intravenous treatment of metastatic colorectal cancer and nonsmall cell lung cancer, but has also been used off label for intravitreal treatment of neovascular AMD.
Med Lett Drugs Ther. 2006 Oct 23;48(1246):85-6 |  Show IntroductionHide Introduction

Blood Test for Tuberculosis

   
The Medical Letter on Drugs and Therapeutics • Oct 08, 2007  (Issue 1271)
Coming Soon in The Medical Letter: Antiviral Drugs for Prophylaxis and Treatment of Influenza ...
Quantiferon - TB Gold (Cellestis) is a T-cell interferon-gamma release assay approved by the FDA as an alternative to the tuberculin skin test for diagnosis of infection with Mycobacterium tuberculosis (TB). An earlier assay (Quantiferon-TB), which is no longer commercially available, was approved by the FDA in 2001. Other interferon-gamma release assays (IGRAs) are available abroad.
Med Lett Drugs Ther. 2007 Oct 8;49(1271):83-4 |  Show IntroductionHide Introduction

Drugs for Stable Angina Pectoris

   
The Medical Letter on Drugs and Therapeutics • Dec 09, 1994  (Issue 937)
. The therapeutic effect lasts for less than an hour, making it unsuitable for long-term prophylaxis ...
Many nitrates, beta-blockers, and calcium-channel blockers have now been approved by the US Food and Drug Administration for treatment of stable angina pectoris. The table beginning on page 112 lists the individual drugs, their dosage, and their cost.
Med Lett Drugs Ther. 1994 Dec 9;36(937):111-4 |  Show IntroductionHide Introduction

Primary Prevention of Ulcers in Patients Taking Aspirin or NSAIDs

   
The Medical Letter on Drugs and Therapeutics • Mar 08, 2010  (Issue 1333)
, placebocontrolled trial. Lancet 2009; 374:119. 5. D Cullen et al. Primary gastroduodenal prophylaxis ...
Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are common causes of peptic ulcer disease. Patients infected with Helicobacter pylori who take aspirin or another NSAID have an especially high risk. Drugs that have been tried for prevention of ulcers in patients taking NSAIDs including H2-receptor antagonists, proton pump inhibitors (PPIs), aluminum- or magnesium-containing antacids, the prostaglandin misoprostol (Cytotec, and others), and antibiotics to eradicate H. pylori.Click here to view the free full...
Med Lett Drugs Ther. 2010 Mar 8;52(1333):17-9 |  Show IntroductionHide Introduction

Nirsevimab (Beyfortus) for Prevention of Severe RSV Disease in Young Children

   
The Medical Letter on Drugs and Therapeutics • Sep 18, 2023  (Issue 1685)
Caserta et al. Palivizumab prophylaxis in infants and young children at increased risk of hospitalization ...
The FDA has approved nirsevimab-alip (Beyfortus – AstraZeneca/Sanofi), a long-acting monoclonal antibody, for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants born during or entering their first RSV season, and in children ≤24 months old who are at increased risk for severe RSV disease through their second RSV season. Nirsevimab is the first drug to be approved for protection of all infants during their first RSV season.
Med Lett Drugs Ther. 2023 Sep 18;65(1685):145-7   doi:10.58347/tml.2023.1685a |  Show IntroductionHide Introduction

Comparison Table: Some Nasal Sprays for Seasonal Allergic Rhinitis (online only)

   
The Medical Letter on Drugs and Therapeutics • Mar 31, 2025  (Issue 1725)
not contain alcohol Other Indications: ▶ Prescription product is also approved for prophylaxis of seasonal ...
View the Comparison Table: Some Nasal Sprays for Seasonal Allergic Rhinitis
Med Lett Drugs Ther. 2025 Mar 31;67(1725):e58-63   doi:10.58347/tml.2025.1725c |  Show IntroductionHide Introduction

Drugs for Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024  (Issue 1708)
-approved for migraine prophylaxis and, as part of a fixed-dose combination with phentermine (Qsymia ...
When used for the appropriate seizure type, antiseizure medications (ASMs) are roughly equivalent in efficacy. In addition to the seizure type, the choice of drug is usually based on factors such as ease of use, spectrum of activity, adverse effects, interactions with other drugs, presence of comorbid conditions, suitability for elderly persons and those with childbearing potential, and cost. Treatment should begin with a single drug, increasing the dosage gradually until seizures are controlled or adverse effects become unacceptable. If seizures persist, expert clinicians generally...
Med Lett Drugs Ther. 2024 Aug 5;66(1708):121-8   doi:10.58347/tml.2024.1708a |  Show IntroductionHide Introduction

Drugs of Choice for Cancer Chemotherapy

   
The Medical Letter on Drugs and Therapeutics • Mar 31, 1995  (Issue 945)
: Vincristine + prednisone + asparaginase + daunorubicin or doxorubicin ± cyclophosphamide CNS prophylaxis ...
Med Lett Drugs Ther. 1995 Mar 31;37(945):25-32 |  Show IntroductionHide Introduction

Cannabis and Cannabinoids

   
The Medical Letter on Drugs and Therapeutics • Nov 18, 2019  (Issue 1585)
) despite optimal prophylaxis with conventional antiemetic drugs such as palonosetron (Aloxi, and others ...
Cannabis (marijuana) contains more than 60 pharmacologically active cannabinoids; delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the best known. THC is the main psychoactive constituent of cannabis. CBD, unlike THC, does not produce intoxication or euphoria.
Med Lett Drugs Ther. 2019 Nov 18;61(1585):179-82 |  Show IntroductionHide Introduction

Drugs of Choice for Cancer

   
Treatment Guidelines from The Medical Letter • Mar 01, 2003  (Issue 7)
prophylaxis: Intrathecal methotrexate or etoposide; high-dose cytarabine + mitoxantrone; (± intrathecal ...
The tables in this article list drugs used for treatment of cancer in the USA and Canada and their major adverse effects. The choice of drugs in Table I is based on the opinions of Medical Letter consultants. Some drugs are listed for indications for which they have not been approved by the US Food and Drug Administration. In some cases, such as elderly patients or those with many co-morbid illnesses, the regimen of choice might not be suitable. For many of the cancers listed, surgery and/or radiation therapy may be the treatment of choice or may also be part of the management. Anticancer...
Treat Guidel Med Lett. 2003 Mar;1(7):41-52 |  Show IntroductionHide Introduction